Nicholas Taylor

Representative Nicholas Taylor's congressional profile remains limited in publicly available biographical information, making detailed background difficult to establish. Based on disclosed financial records, Taylor reported 4 stock transactions during a concentrated one-month period in November 2022, with positions in pharmaceutical giants Bristol-Myers Squibb (BMY) and Eli Lilly (LLY), credit rating agency Moody's (MCO), and Samsung Electronics (SSLTY). His trading activity reflects an estimated volume range of $1.8M to $6.5M, suggesting substantial portfolio positioning during that brief window. Notably, Taylor has shown no recent trading activity in the past 90 days, indicating either a shift away from active trading or a pause in reportable transactions following his initial disclosure period.